Healthcare provider profile · identity verified

Afroze Muneer, M.D.

Internal Medicine · BALTIMORE, MD · NPI 1033103056

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	384	128
Amlodipine Besylate	Amlodipine Besylate	282	84
Albuterol Sulfate Hfa	Albuterol Sulfate	277	66
Metformin Hcl	Metformin Hcl	263	74
Levothyroxine Sodium	Levothyroxine Sodium	224	62
Metoprolol Succinate	Metoprolol Succinate	218	54
Lisinopril	Lisinopril	196	56
Omeprazole	Omeprazole	194	52
Hydrochlorothiazide	Hydrochlorothiazide	184	49
Pantoprazole Sodium	Pantoprazole Sodium	174	52
Losartan Potassium	Losartan Potassium	171	51
Gabapentin	Gabapentin	158	42
Eliquis	Apixaban	157	32
Sertraline Hcl	Sertraline Hcl	152	44
Fluticasone Propionate	Fluticasone Propionate	133	73
Hydroxyzine Hcl	Hydroxyzine Hcl	121	46
Pravastatin Sodium	Pravastatin Sodium	121	38
Rosuvastatin Calcium	Rosuvastatin Calcium	118	43
Furosemide	Furosemide	116	38
Zolpidem Tartrate	Zolpidem Tartrate	110	14
Metoprolol Tartrate	Metoprolol Tartrate	102	31
Tamsulosin Hcl	Tamsulosin Hcl	99	20
Atenolol	Atenolol	85	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	23
Jardiance	Empagliflozin	84	17
Potassium Chloride	Potassium Chloride	79	19
Alprazolam	Alprazolam	78	16
Clopidogrel	Clopidogrel Bisulfate	78	19
Simvastatin	Simvastatin	69	18
Trazodone Hcl	Trazodone Hcl	69	20
Famotidine	Famotidine	68	16
Bupropion Xl	Bupropion Hcl	62	20
Carvedilol	Carvedilol	62	21
Clonazepam	Clonazepam	61	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	58	18
Tramadol Hcl	Tramadol Hcl	52	suppressed
Ozempic	Semaglutide	51	15
Diclofenac Sodium	Diclofenac Sodium	49	24
Hydralazine Hcl	Hydralazine Hcl	49	12
Tizanidine Hcl	Tizanidine Hcl	46	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Nystatin	Nystatin	43	21
Citalopram Hbr	Citalopram Hydrobromide	41	14
Meloxicam	Meloxicam	40	16
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Mirtazapine	Mirtazapine	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	34	suppressed
Amoxicillin	Amoxicillin	34	26
Lansoprazole	Lansoprazole	32	suppressed
Methylprednisolone	Methylprednisolone	32	30
Doxycycline Monohydrate	Doxycycline Monohydrate	31	30
Ezetimibe	Ezetimibe	31	13
Lorazepam	Lorazepam	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Spironolactone	Spironolactone	29	13
Allopurinol	Allopurinol	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Prednisone	Prednisone	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Etodolac	Etodolac	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Ibuprofen	Ibuprofen	22	12
Isosorbide Dinitrate	Isosorbide Dinitrate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	16	suppressed
Linzess	Linaclotide	16	suppressed
Topiramate	Topiramate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Glipizide	Glipizide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error